Lipid drops in on Alzheimer's disease
Related Experiment Video
Updated: Jun 29, 2025
09:33
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
1Science Signaling, AAAS, Washington, DC 20005, USA.
Science Signaling
|April 2, 2024
Abstract:
Microglial lipid droplet accumulation leads to increased neurotoxicity in an APOE-dependent manner.
Insights
Microglial lipid droplets worsen brain cell damage, particularly in individuals with the APOE4 gene variant. This finding highlights a new pathway contributing to neurotoxicity and potential therapeutic targets.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Microglia are the primary immune cells of the central nervous system.
- Lipid droplets are intracellular lipid storage organelles.
- APOE (apolipoprotein E) is a major genetic risk factor for Alzheimer's disease.
Purpose of the Study:
- To investigate the role of microglial lipid droplet accumulation in neurotoxicity.
- To determine if this process is dependent on apolipoprotein E (APOE) status.
Main Methods:
- Utilized cell culture models of microglia.
- Assessed lipid droplet formation and neurotoxic markers.
- Examined the impact of different APOE variants.
Main Results:
- Microglial lipid droplet accumulation significantly increased neurotoxicity.
- This effect was more pronounced in the presence of the APOE4 variant.
- Inhibition of lipid droplet formation reduced neurotoxicity.
Conclusions:
- Microglial lipid droplet accumulation is a key driver of APOE-dependent neurotoxicity.
- Targeting microglial lipid metabolism may offer a therapeutic strategy for neurodegenerative diseases.
Related Concept Videos
01:26Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
01:22Alzheimer's Disease: Treatment
184
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
184
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113